Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

The Semaglutide peptide has emerged as a compelling subject in biochemical and physiological research due to its potential ...

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of ...

The PIL seeks a ban on the marketing and distribution of specific GLP-1 receptor agonist (RA) drugs, namely Semaglutide, ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

The Delhi High Court on Wednesday directed the Central Drugs Standard Control Organisation (CDSCO) to decide, within 3 month ...

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

In a paper released in Addiction, scientists reported that people with a history of alcohol use disorder who were prescribed these medications were 50% less likely to binge drink. The results were ...